Skip to Content

IN17-01a

Main Content

Incidence and impact of cytomegalovirus infection in haploidentical and matched-related donors receiving post-transplant cyclophosphamide: A CIBMTR analysis.

Study #: IN17-01a

Study Status: Published

Presentation(s)

2020, TCT Meetings (Oral)

Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.

Citation

Goldsmith SR, Abid MB, Auletta JJ, Bashey A, Beitinjaneh A, Castillo P, Chemaly RF, Chen M, Ciurea S, Dandoy CE, Díaz MÁ, Fuchs E, Ganguly S, Kanakry CG, Kanakry JA, Kim S, Komanduri KV, Krem MM, Lazarus HM, Liu H, Ljungman P, Maziarz R, Mulroney C, Nathan S, Nishihori T, Page KM, Perales M-A, Taplitz R, Romee R, Riches M.

Blood. 2021, Jun 10: 137(23): 137(23):3291-3305. doi: 10.1182/blood.2020009362. Epub 2021, Mar 03. PMCID:PMC8351903.

PubMed

PMID: 33657221

Abstract